These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7387254)

  • 21. Relationship between the sympatholytic action of nebivolol and hypotension.
    Ward JE; Coles P; Cox H; Eisenhofer G; Angus JA
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):115-24. PubMed ID: 1383620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative antihypertensive effects and tissue distribution of beta adrenergic blocking drugs.
    Garvey HL; Ram N
    J Pharmacol Exp Ther; 1975 Jul; 194(1):220-33. PubMed ID: 1151751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial sensitivity to isoproterenol following abrupt propranolol withdrawal in conscious dogs.
    Webb JG; Newman WH; Walle T; Daniell HB
    J Cardiovasc Pharmacol; 1981; 3(3):622-35. PubMed ID: 6168842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of indomethacin on hemodynamic parameters after intravenous administration of propranolol and enalaprilat in rabbits.
    Kasznicki J; Wiktorowska-Owczarek A
    Pol J Pharmacol; 2001; 53(5):487-93. PubMed ID: 11990067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of the hypotensive effect of a new beta-adrenergic blocking drug, arotinolol (S-596) in anesthetized rabbits.
    Nakahara H; Nakazawa M; Tsukada T; Imai S
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):253-63. PubMed ID: 2415080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C1 area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol.
    Privitera PJ; Granata AR; Underwood MD; Gaffney TE; Reis DJ
    J Pharmacol Exp Ther; 1988 Aug; 246(2):529-33. PubMed ID: 3404445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac actions of central but not peripheral urotensin II are prevented by beta-adrenoceptor blockade.
    Hood SG; Watson AM; May CN
    Peptides; 2005 Jul; 26(7):1248-56. PubMed ID: 15949643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers.
    Kähönen M; Ylitalo R; Kööbi T; Turjanmaa V; Ylitalo P
    Int J Clin Pharmacol Ther; 1998 Sep; 36(9):483-9. PubMed ID: 9760009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypotensive action of propranolol and a new beta-blocking agent, D-32 in conscious normotensive and renal hypertensive dogs.
    Himori N; Izumi A; Hiramatsu Y
    Arch Int Pharmacodyn Ther; 1976 Mar; 220(1):4-18. PubMed ID: 8021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular and respiratory effects of beta-endorphin in anesthetized and conscious rats.
    Sitsen JM; Van Ree JM; De Jong W
    J Cardiovasc Pharmacol; 1982; 4(6):883-8. PubMed ID: 6185778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intracisternal application of 6-hydroxydopamine on the antihypertensive action of propranolol in the dog.
    Montastruc JL; Montastruc P
    Eur J Pharmacol; 1980 May; 63(2-3):103-16. PubMed ID: 6247163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional and anatomical organization of cardiovascular pressor and depressor sites in the lateral hypothalamic area: I. Descending projections.
    Allen GV; Cechetto DF
    J Comp Neurol; 1992 Jan; 315(3):313-32. PubMed ID: 1740546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canine cardiovascular responses to endotracheally and intravenously administered atropine, isoproterenol, and propranolol.
    Scott B; Martin FG; Matchett J; White S
    Ann Emerg Med; 1987 Jan; 16(1):1-10. PubMed ID: 3800058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aortic peak flow velocity as an index of myocardial contractility in the conscious rat.
    Dowell RT; Houdi AA
    Methods Find Exp Clin Pharmacol; 1997 Oct; 19(8):533-9. PubMed ID: 9442476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of propranolol HCl in hippocampal-lesioned rats.
    Ram N; Hesse UC; Heilman RD
    Arch Int Pharmacodyn Ther; 1977 Sep; 229(1):138-43. PubMed ID: 931460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the central muscle relaxant activity of D.C.I., nethalide and propranolol.
    Sinha JN; Srimal RC; Jaju BP; Bhargava KP
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):160-6. PubMed ID: 4382142
    [No Abstract]   [Full Text] [Related]  

  • 40. Central antihypertensive effects of propranolol in the spontaneously hypertensive rat.
    Sweet CS; Wenger HC
    Neuropharmacology; 1976 Aug; 15(8):511-3. PubMed ID: 980226
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.